CIK 0001107421 · Non-accelerated filer<br>Smaller reporting company
Alaunos Therapeutics, Inc.
Sign in to watch- Ticker
- TCRT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 841475642
- Phone
- (346) 355-4099
- Business address
- 501 E LAS OLAS BLVD, SUITE 300, FORT LAUDERDALE, FL, 33301
- Former names
- ZIOPHARM ONCOLOGY INC, EASYWEB INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-06 | Weis Holger Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2023-03-30 | Hofmeister Robert Director | Grant or award · Employee Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-03-30 | Hofmeister Robert Director | Grant or award · Employee Stock Option (right to buy) | +16,667 | 16,667 | ||
| 2023-03-15 | Srivastava Abhishek K See Remarks | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-03-15 | Wong Michael Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-03-15 | Boyle Kevin S. Sr. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +1,800,000 | 1,800,000 | ||
| 2023-03-15 | Deniger Drew See Remarks | Grant or award · Employee Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2023-03-15 | Lackey Melinda See Remarks | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | ||
| 2022-11-29 | Postma Robert W Director | Purchase | +750,000 | $0.65 | $488K | 5,000,000 |
| 2022-11-29 | Vieser Jaime Director | Purchase | +1,250,000 | $0.65 | $813K | 1,250,000 |
| 2022-09-15 | Deniger Drew VP, Research and Development | Grant or award · Employee Stock Option (right to buy) | +305,000 | 305,000 | ||
| 2022-09-15 | Srivastava Abhishek K See Remarks | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2022-09-15 | Wong Michael VP, Finance | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-09-15 | Lackey Melinda Senior Vice President, Legal | Grant or award · Employee Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2022-08-30 | Boyle Kevin S. Sr. Chief Executive Officer | Shares withheld for taxes | −18,750 | $2.41 | $45K | 866,250 |
| 2022-08-12 | Srivastava Abhishek K See Remarks | Grant or award · Employee Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2022-06-22 | Thistle Mary Director | Grant or award | +40,000 | 45,000 | ||
| 2022-06-22 | Thistle Mary Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2022-06-22 | Huang James Director | Grant or award | +80,000 | 188,333 | ||
| 2022-06-22 | Huang James Director | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 |
Page 4 of 16 · 304 trades